HWABAO WP FUND MANAGEMENT CO LTD HWABAO CSI MEDICAL ETFHWABAO WP FUND MANAGEMENT CO LTD HWABAO CSI MEDICAL ETFHWABAO WP FUND MANAGEMENT CO LTD HWABAO CSI MEDICAL ETF

HWABAO WP FUND MANAGEMENT CO LTD HWABAO CSI MEDICAL ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪26.09 B‬CNY
Fund flows (1Y)
‪2.92 B‬CNY
Dividend yield (indicated)
Discount/Premium to NAV
−0.2%
Shares outstanding
‪78.47 B‬
Expense ratio
0.60%

About HWABAO WP FUND MANAGEMENT CO LTD HWABAO CSI MEDICAL ETF


Issuer
Hwabao WP Fund Management Co., Ltd.
Brand
Hwabao
Home page
Inception date
May 20, 2019
Structure
Open-Ended Fund
Index tracked
CSI Medical Index Yield - Benchmark TR Gross
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Hwabao WP Fund Management Co., Ltd.
ISIN
CNE100003KS0
The index of the target is closely tracked, and the tracking deviation and tracking err are minimized

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Vanilla
Geography
China
Weighting scheme
Market cap
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of December 31, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Health Services
Stocks98.25%
Health Technology73.71%
Health Services14.01%
Process Industries5.83%
Distribution Services1.63%
Technology Services1.61%
Producer Manufacturing0.84%
Commercial Services0.34%
Consumer Non-Durables0.28%
Bonds, Cash & Other1.75%
Cash1.75%
Stock breakdown by region
100%
Asia100.00%
North America0.00%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


512170 invests in stocks. The fund's major sectors are Health Technology, with 73.71% stocks, and Health Services, with 14.01% of the basket. The assets are mostly located in the Asia region.
512170 top holdings are Shenzhen Mindray Bio-Medical Electronics Co., Ltd. Class A and WuXi AppTec Co., Ltd. Class A, occupying 10.24% and 9.89% of the portfolio correspondingly.
512170 assets under management is ‪26.09 B‬ CNY. It's risen 1.68% over the last month.
512170 fund flows account for ‪2.86 B‬ CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 512170 doesn't pay dividends to its holders.
512170 shares are issued by Hwabao WP Fund Management Co., Ltd. under the brand Hwabao. The ETF was launched on May 20, 2019, and its management style is Passive.
512170 expense ratio is 0.60% meaning you'd have to pay 0.60% of your investment to help manage the fund.
512170 follows the CSI Medical Index Yield - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
512170 invests in stocks.
512170 price has risen by 4.08% over the last month, and its yearly performance shows a 2.15% increase. See more dynamics on 512170 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 5.58% over the last month, showed a −4.94% decrease in three-month performance and has increased by 4.14% in a year.
512170 trades at a premium (0.27%) meaning the ETF is trading at a higher price than the calculated NAV.